Healthcare News
-
-
Cummings Graduate Institute for Behavioral Health Studies Celebrates New DBH Graduates
-
Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
-
AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
-
$328 Million Global Stroke Rehab Market Opportunity Awaits AI Telehealth Leader Following Selection for NIH Funded Phase 3 Clinical Study: VSee Health
-
Coker Completes Acquisition of Healthcare Cost Solutions, a Leading Expert in Technology-Enabled Compliance Services
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Biotech, Stocks, Stock Market, Financial, Nasdaq
$750 Million Ketamine Drug Market Withing Reach via New Commissioner's National Priority Vouchers with Anticipated Approval by Year-End for NRx
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Biotech, Stocks, Stock Market, Financial, Nasdaq$750 Million Market Projected to Reach $3.3 Billion Globally in 2034 for New Drug Application Filed on Preservative-Free IV Ketamine: NRx Pharma, Inc
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Biotech, Stocks, Stock Market, Financial, NasdaqCEO Selected to Present at Wall Street Conference on May 21, 2025 for Suicidal Depression / PTSD: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Biotech, Stocks, Stock Market, Financial, Nasdaq$7.8M Financing Boosts NRx's Expansion with Kadima Institute Acquisition for PTSD and Depression Care: NRx Pharmaceuticals, Inc. (Stock Symbol: NRXP)
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Biotech, Stocks, Stock Market, Financial, NasdaqPlan Signed to Purchase Kadima Neuropsychiatry Institute as Clinical Treatment Model and Leading Investigative Site Addressing Suicidal Depression
-
$34 Billion Market in 2025 Advancing to $45 Billion in 2026 for Phase III Development of New Blood Thinner, Less Problematic Than Warfrain: $CVKD
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Biotech, Stocks, Stock Market, Financial, Nasdaq$4.3 Million Patent Application Waiver Fee Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression & PTSD: NRX Pharma
- Miami, Finance, Medical, Health, Marketing, Banking, Media, Biotech, Stocks, Stock Market, Financial, Nasdaq$4.3 Million Waiver Exemption Granted by FDA on New Drug Application Fee for Treatment Addressing Suicidal Depression, PTSD: NRx: Stock Symbol: NRXP
Ironside HR Named Fastest-Growing Staffing Firm for Second Year